• Sinjjn Smythe
    THLD$6.19 time to start buying again! From phase 2 data and orphan status it looks like THLD will get another chunk of millions from Merck!
    4/19/12
    Reply (7)
    • Sinjjn Smythe: THLD in $6 range is crazy, Anything under $10 is a steal. $525 Million is on table with Merck deal as well as Merck's guidance through FDA!
      4/19/12
    • Sinjjn Smythe: I buy mgmt and Merck has protected its investment by helping THLD get orphan drug status in amazing time through both US FDA and European.
      4/19/12
    • Sinjjn Smythe: I was reading up on their Phase 2 final results and it cemented their original data and even surprised with how strong final results were.
      4/19/12
    • Sinjjn Smythe: This drug is a game changer in the way other cancers will be treated in the future. Great mgmt and great drug and strong partner in Merck!
      4/19/12
    • Sinjjn Smythe: I started buying at $1.67 and have been adding through ups and downs and now have added more! I have only 2 positions in market, THLD & S
      4/19/12
    • Sinjjn Smythe: They have both whether all the market ups and downs because they have strong fundamentals in great mgmt, assets, partners.
      4/19/12
    • Sinjjn Smythe: I expect THLD to be bought out. Its drug is way too valuable to a big player like Merck!
      4/19/12